Medica Venture Partners

Medica Venture Partners is a globally operating health care and life sciences venture capital fund investing in Israel, Europe and the United States providing equity financing, management assistance and expertise to early stage startups and seed stage companies in all areas of health care and life science technologies; from medical devices to pharmaceuticals, biotech and genomics. Medica co-invests with some of the top health care funds in the world and has an extensive and unique operational base and infrastructure in Israel.

Medica Venture Partners, established in 1995 and headquartered in Asia., specializes in Late Stage Venture, Early Stage Venture investments across Biotechnology, Health Care, Medical, Medical Device, Financial Services, Finance, Pharmaceutical, Venture Capital, Advice, Life Science. The organization boasts a portfolio of 17 investments, with an average round size of $15.0M and 7 successful exits. Their recent investments include FlowMedica, DeNovo Ventures, Oxford Bioscience Partners, Palo Alto Investors, Regentis Biomaterials. The highest investment round they participated in was $18.5B. Among their most notable exits are FlowMedica and DeNovo Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.